$EYPT News Article - EyePoint Pharmaceuticals Announces Positive 12-Month Safety and Efficacy Data from Phase 1 DAVIO Clinical Trial Evaluating EYP-1901 for the Treatment of Wet AMD https://marketwirenews.com/news-releases/eyep...29438.html
(0)
(0)
EyePoint Pharmaceuticals Inc. (EYPT) Stock Research Links